49th ANZSN

 
AU Newsletter Conference Announcement ANZSN icon

Fresenius Medical Care shared recent study results on HighVolume HDF, as well as APD

This year’s ANZSN provided Fresenius Medical Care the opportunity to share the latest insights into new therapy modalities in Haemodialysis, as well as Peritoneal Dialysis.

The 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN ASM) was held from 9-11 September 2013 in Brisbane, Queensland to share scientific and medical advances in Nephrology.  The event attracted over 300 local, national and international delegates including nephrologists, trainees, scientists, allied health professionals and nurses over three days, making it one of Australia’s most impressive scientific conferences for 2013. The high-calibre and multi-disciplinary scientific and nephrology based programme featured advancing therapeutic options for dialysis patients.

Fresenius Medical Care (FME), a sustaining member and sponsor of the ANZSN, focused on latest scientific news on HighVolume Online HDF (OL-HDF) at their booth. We shared the recently published ESHOL (Estudio de Supervivencia de Hemodiafiltracion On-Line; On-Line Haemodiafiltration Survival Study) study demonstrating that HighVolume OL-HDF therapy improves patients’ survival rate. With a 30% reduction of all-cause mortality and 33% lower risk of cardiovascular mortality patients should benefit from this therapy modality. In addition the authors also calculated reduced treatment costs due to a 22% risk reduction in all-cause hospitalization.1 Find out more about ESHOL by clicking here.
    
FME also demonstrated the new ‘5008 Therapy System - Beyond your expectations’ technology platform that will revolutionise the management of ESRD with the aim to improve patient outcomes. The enhanced 5008 software provides improved therapy options, safety features and handling capabilities. With ready access to AutoSubPlus, clinicians can maximise the effects of haemodiafiltration (HDF) by delivering high substitution volumes with the security of additional haemoconcentration monitoring.

A recent development in Automated Peritoneal Dialysis (APD) was also featured by Fresenius Medical Care. In combining sequences of short dwells and small fill volumes with long dwells and large fill volumes, aAPD (adapted APD) promotes ultrafiltration (UF) and clearance within one PD session. Compared with conventional APD, by targeting UF and clearance separately, aAPD increases dialysis efficiency with a reduction in glucose absorption.2

To find out more information about HighVolumeHDF or Adapted APD, please contact us here.

References:

  1. Maduell F, Moreso F, Pons M: High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients. J Am Soc Nephrol 24, 2013
  2. Fischbach M, Issad B, Dubois V, Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): a randomized controlled trial. Perit Dial Int 2011; Jul-Aug;31(4):450-8